Search

everythinglearnresearchcommunity

for

Search:↓

PRP treatment may increase hair density and reduce hair loss, but more research is needed.

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Azathioprine can help with relapses and disability in NMOSD but has more side effects and needs more research.

Genetic variations affecting skin structure play a key role in severe acne.

Many COVID-19 survivors experience long-lasting symptoms, including hair loss and psychological issues.

Dutasteride more effectively treats hair loss than finasteride, but may increase risk of altered libido.

Oral JAK inhibitors are effective and safe for treating alopecia areata but may need ongoing use to keep results.

Leflunomide and methotrexate are equally effective for rheumatoid arthritis but have different side effects.

Vertex pattern hair loss linked to higher prostate cancer risk.

Male cancer patients have a higher risk of severe illness and death from COVID-19 than female patients.

Severe baldness on the top of the head is linked to a higher chance of heart disease, especially in men under 60.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

Minoxidil effectively and safely treats patchy hair loss, but more research needed.

Women with PCOS have higher 5α-reductase activity, which may be linked to insulin resistance.

Many people experience hair loss after weight loss surgery, especially younger women, and it's linked to lower levels of zinc, folic acid, and ferritin.

The study found key factors in the cause of hidradenitis suppurativa, its link to other diseases, and identified existing drugs that could potentially treat it.

Stem cell therapy helps heal burn wounds, especially second-degree burns, by promoting blood vessel growth and reducing inflammation.

PRP treatment increases hair density and thickness in androgenetic alopecia by 79%.

Finasteride and dutasteride increase sexual dysfunction risk by 1.57 times in male hair loss treatment.

Valproic acid increases the risk of hair loss more than other drugs, especially in migraine patients, and lamotrigine may be a safer alternative.

Isotretinoin is effective for treating dissecting cellulitis, but recurrence is common.

Topical minoxidil significantly increases hair growth in androgenetic alopecia but only some patients see cosmetically acceptable results.

Combination therapies work better than single treatments for hair loss.

FDA-approved low-level light/laser therapy devices can significantly increase hair density in people with pattern hair loss.

Finasteride and minoxidil together safely and effectively increase hair growth and density for androgenetic alopecia.

Anti-androgens can help manage some PCOS symptoms better than metformin but are not more effective than placebos or birth control pills for other symptoms.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

PRP shows promise for treating female hair loss but needs more research.

People with hidradenitis suppurativa have a higher risk of heart attacks and strokes.